Rational discovery of novel nuclear hormone receptor antagonists.

Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.

In silico discovery of novel retinoic acid receptor agonist structures.

Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking.

Nuclear hormone receptor targeted virtual screening.

Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins.

In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cells.

Discovery of bioactive small-molecule inhibitor of poly adp-ribose polymerase: implications for energy-deficient cells.

In silico prediction of SARS protease inhibitors by virtual high throughput screening.

Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.